Top 50 Medical Device Startup Investors in Ireland (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
53 | Ireland, United States, United Kingdom | Seed, Venture - Series Unknown, Grant | Software, Health Care, Information Technology | $16k–$8.3M |
|
Western Development Commission
VC Fund
|
19 | Ireland, United States | Seed, Venture - Series Unknown, Series A | Health Care, Medical Device, Biotechnology | $702k–$17M |
|
HBAN
VC Fund
|
15 | Ireland, United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Software, Medical Device | $375k–$7.3M |
|
Irrus Investments
VC Fund
|
14 | Ireland, Sweden, United States | Seed, Venture - Series Unknown, Series A | Health Care, Medical Device, Biotechnology | $713k–$24M |
|
Atlantic Bridge University Fund
VC Fund
|
12 | Ireland, United States | Seed, Series A, Series B | Health Care, Medical Device, Big Data | $859k–$80M |
|
Elkstone Capital Partners
VC Fund
|
10 | Ireland, United Kingdom, United States | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $797k–$18M |
|
SOSV
VC Fund
|
10 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
HBAN Medtech Syndicate
VC Fund
|
10 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | $1.3M–$11M |
|
Furthr VC
VC Fund
|
9 | Ireland | Seed, Venture - Series Unknown | Software, Medical Device, Medical | $753k–$17M |
|
Atlantic Bridge
VC Fund
|
9 | United States, Ireland, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Information Technology | $1.1M–$62M |
|
Enterprise Equity
VC Fund
|
7 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Health Care | $549k–$7.5M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
EIT Health
VC Fund
|
6 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $27k–$1.7M |
|
EQT Life Sciences
VC Fund
|
5 | United States, Switzerland, The Netherlands | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.3M–$165M |
|
Business Venture Partners
VC Fund
|
5 | Ireland, The Netherlands, Luxembourg | Seed, Series A | Health Care, Information Technology, Medical | $665k–$12M |
|
Ascentifi
VC Fund
|
5 | Ireland | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Medical | $2.3M–$34M |
|
Faber
VC Fund
|
5 | Portugal, Germany, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $121k–$25M |
|
Act Venture Capital
VC Fund
|
5 | Ireland, United States, United Kingdom | Seed, Series A | Software, Artificial Intelligence, Information Technology | $1M–$13M |
|
Boole Investment Syndicate
VC Fund
|
4 | Ireland, Estonia, United States | Seed, Series A | Biotechnology, SaaS, Software | $623k–$2.2M |
|
Boole
VC Fund
|
4 | Ireland | Seed | Health Care, Medical Device, Medical | $2M–$4.2M |
|
Delta Partners
VC Fund
|
4 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $812k–$6.6M |
|
AIB Seed Capital Fund
VC Fund
|
4 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $549k–$8.1M |
|
Xenium Capital
VC Fund
|
4 | Ireland | Seed | Medical Device, Health Care, Biotechnology | $2.6M–$4.2M |
|
Broadview Ventures
VC Fund
|
3 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Energy, Health Care | $8.7M–$587M |
|
SciFounders
VC Fund
|
3 | United States, Ireland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Medical | $400k–$21M |
|
Lightstone Ventures
VC Fund
|
3 | United States, Ireland, India | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $18M–$105M |
|
NDRC
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, Information Technology, E-Commerce | |
|
Seroba Life Sciences
VC Fund
|
3 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
Medtech Syndicate Nominee
VC Fund
|
3 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
Artis Ventures
VC Fund
|
2 | United States, United Kingdom, India | Series A, Series B, Seed | Health Care, Biotechnology, Software | $2.1M–$127M |
|
Glanzmann Enterprises
VC Fund
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
|
Pareto Holdings
VC Fund
|
2 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $125k–$35M |
|
Gilde Healthcare
VC Fund
|
2 | United States, The Netherlands, Germany | Series B, Series C, Series A | Health Care, Biotechnology, Medical | $9.5M–$135M |
|
Cantor Fitzgerald
VC Fund
|
2 | United States, Canada, Ireland | Post-IPO Equity, Debt Financing, Series B | Biotechnology, Energy, Software | $6.4M–$195M |
|
CAJU Venture Partners
VC Fund
|
2 | Ireland | Health Care, Medical Device | ||
|
Life Sciences Fund Amsterdam
VC Fund
|
2 | Ireland, United States, The Netherlands | Series A, Private Equity | Medical, Health Care, Biotechnology | $11M–$61M |
|
Kernel Capital
VC Fund
|
2 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $531k–$9M |
|
Foresight Group
VC Fund
|
2 | United Kingdom, United States, Ireland | Venture - Series Unknown, Private Equity, Seed | Software, Information Technology, Manufacturing | $648k–$8.3M |
|
Lynett Capital
VC Fund
|
2 | United States, Kenya, Nigeria | Seed, Series A, Pre-Seed | FinTech, SaaS, Software | $230k–$49M |
|
Oyster Capital Partners
VC Fund
|
2 | Ireland, United Kingdom, United States | Series A, Seed, Venture - Series Unknown | Software, SaaS, Health Care | $1.2M–$97M |
|
Mayo Clinic Ventures
VC Fund
|
2 | United States, Israel, Ireland | Seed, Series A, Series B | Health Care, Biotechnology, Therapeutics | $1.4M–$60M |
|
Chip Hance
Angel
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
|
imec.xpand
VC Fund
|
2 | Belgium, United States, Germany | Seed, Series A, Series B | Semiconductor, Manufacturing, Medical Device | $3.3M–$100M |
|
Gaingels
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $69k–$35M |
|
Business Growth Fund
VC Fund
|
2 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Manufacturing, Information Technology | $3.4M–$22M |
|
Lachy Groom
Angel
|
2 | United States, India, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2.2M–$80M |
|
Silicon Valley Bank
VC Fund
|
2 | United States, Canada, United Kingdom | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $2M–$105M |
|
Trinity Biotech
VC Fund
|
2 | Ireland, United States | Seed, Corporate Round, Convertible Note | Health Care, Wellness, Medical Device | |
|
Partisan Management Group
VC Fund
|
2 | United States, Ireland | Series A, Series B | Medical, Health Care, Biotechnology | $6.1M–$50M |
| Access all 188 investors in Ireland Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Grant
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 890
- Round size: Seed $399k–$3.2M; Grant $16k–$5.5M; Venture - Series Unknown $560k–$8.3M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2021
Portfolio highlights
- Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
- Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
- Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 45
- Round size: Seed $702k–$3.9M; Series A $2.2M–$11M; Venture - Series Unknown $753k–$17M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 74
- Round size: Seed $623k–$3.6M; Venture - Series Unknown $375k–$7.3M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
- Glitch Ads — GlitchAds intends to democratize advertising by "leveraging" adverts and artificial intelligence.
- Change by Degrees — Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$4.7M; Series A $2.2M–$9.2M; Venture - Series Unknown $1.2M–$24M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Health Care, Medical Device, Big Data
- Stage:Seed, Series A, Series B
- Geography: Ireland, United States
Investor stats
- Total investments: 33
- Round size: Seed $859k–$4.2M; Series A $3.4M–$34M; Series B $16M–$80M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- PlasmaBound — PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 98
- Round size: Seed $797k–$5.8M; Series A $5.5M–$18M; Venture - Series Unknown $1.1M–$7.8M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
- ZeroRisk.io — https://t.co/Aukldsyhoy is the end-to-end merchant portfolio risk and compliance management system designed to make the payments ecosystem safer.
- Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 13
- Round size: Seed $1.3M–$11M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more...Investment focus
- Industry: Software, Medical Device, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland
Investor stats
- Total investments: 31
- Round size: Seed $797k–$6.3M; Venture - Series Unknown $753k–$17M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $36M in 2019
Portfolio highlights
- WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 154
- Round size: Seed $1.1M–$7.5M; Series A $5M–$26M; Series B $10M–$62M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- GloNav — GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellularhandset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.
- Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 57
- Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $140M in 2019
Portfolio highlights
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 106
- Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, The Netherlands
Investor stats
- Total investments: 189
- Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $282M in 2023
Portfolio highlights
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
- Vaderis Therapeutics — Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Ireland, The Netherlands, Luxembourg
Investor stats
- Total investments: 34
- Round size: Seed $665k–$4.7M; Series A $2.3M–$12M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Advise — Advise Freemium is a ground-breaking automated data analytics for CPG solution. Discover how Advise can assist your Revenue Growth Management.
- Oranda Therapeutics — Oranda Therapeutics: ensuring sustainable, affordable access to rare disease medicines across Europe through high-quality established treatments.
- The Corporate Governance Institute — Diploma Certification for Board Directors. University accredited Courses for existing and aspiring Directors. Qualify as a Director.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Ireland
Investor stats
- Total investments: 9
- Round size: Seed $2.3M–$11M; Series A $9.2M–$34M; Venture - Series Unknown $3M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
- X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Germany, United Kingdom
Investor stats
- Total investments: 100
- Round size: Seed $595k–$5.2M; Pre-Seed $121k–$3M; Series A $2.5M–$25M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fresh fund, raised $34M in 2024
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- Helix Robotics — We are building the first commercial soft manipulator
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 165
- Round size: Seed $1M–$5M; Series A $2.3M–$13M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $146M in 2022
Portfolio highlights
- Ubotica — AI-powered maritime surveillance and intelligence that predicts risk, tasks satellites and delivers verified insights to protect critical infrastructure and detect dark vessels.
- Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
- Fresco — Fresco powers connected cooking experiences for appliance brands, enabling faster launches, lower R&D costs, and continuous innovation.
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more...Investment focus
- Industry: Biotechnology, SaaS, Software
- Stage:Seed, Series A
- Geography: Ireland, Estonia, United States
Investor stats
- Total investments: 10
- Round size: Seed $623k–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
- ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
Boole
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $2M–$4.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Incereb — Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. Founded in May 2011, Incereb is headquartered in Dublin, Ireland. The company designs and develops disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products for term and preterm infants (neonates).These intuitive products are designed to be used with minimal training and will significantly reduce the time taken to set up the neonate for EEG and CFM monitoring. Their products are designed to interface with all brands of EEG and CFM recording equipment.Incereb is an award winning early stage company that plans to invest heavily in R&D, product design and development to evolve and extend its product range. Strategic alliances with leading Irish universities and hospitals enable Incereb to leverage home-grown scientific excellence to facilitate fast commercialisation of novel devices leading to rapid growth.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 116
- Round size: Seed $812k–$3M; Series A $1.6M–$6.6M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $76M in 2022
Portfolio highlights
- CleverCards — The Platform for Contactless Cards. The CleverGift real-time payment platform offers gift cards, expenses, employee incentives, and travel foreign exchange.
- Bloomberg PolarLake — Streamline the acquisition, management and distribution of instrument, pricing, index, legal and ratings data from multiple delivery channels.
- WhatClinic.com — WhatClinic.com helps patients find, compare and book the right clinics for them, in more than 135 countries. They provide detailed listings for over 120,000 clinics on their site. These include doctors, dentists, beauty and cosmetic surgery, physiotherapy, fertility, holistics and a lot more. They believe that every patient is an empoweredconsumer.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $549k–$3.6M; Series A $1.1M–$8.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Xenium Capital
Show more...Investment focus
- Industry: Medical Device, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $2.6M–$4.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 85
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 595
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
We invest in highly technical startups from idea-stage up to Series A.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $3.2M–$5M; Pre-Seed $400k–$400k; Series A $2.5M–$21M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $2.5M in 2024
Portfolio highlights
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
- Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, India
Investor stats
- Total investments: 88
- Round size: Series A $20M–$95M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Cerevance — Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, thecompany generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.
- Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
- Crystalys Therapeutics — Transforming care for people living with gout.
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 110
- Lead/follow: no public data
Portfolio highlights
- Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
- Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
- Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $108M in 2017
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 151
- Round size: Seed $2.1M–$35M; Series A $5M–$57M; Series B $20M–$127M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $141M in 2023
Portfolio highlights
- GenHealth.ai — GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events usinghistorical events. Together they can be used to build a large variety of customized applications.
- Ozlo Sleep — Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.
- Stateless Networks — Performance, Visibility. Simplicity...It's time for a beautiful network. Stateless is transforming network operations for software-centric networking. Tying together deep network understanding with state-of-the-art distributed systems, cloud, data science and gaming expertise, Stateless transforms network visibility, performance andresponse and helps accelerate the transition to modern network platforms, tying together physical and virtual layers. Focused on the enterprise data center, Stateless currently partners with the world’s leading network and infrastructure vendors (including VMware (VMW), Cisco Systems (CSCO), Cumulus Networks and others) to deliver solutions to some of the world’s largest private data center operators. We’re looking for software and networking engineers in Greater Seattle and the Bay Area with expertise in one or more of the following areas: Distributed Systems, Service Oriented Architecture, Complex Event processing, Functional Programming, Virtualization, Network design and deployment, Network programming, Network troubleshooting, configuration and performance tuning and SDN. Bonus points for experience working with cloud infrastructure (AWS, Azure, OpenStack) or low-level systems software (linux kernel, hypervisors, compilers/language runtimes), complex gaming systems or graphics and computational geometry. For more information visit http://www.statelessnetworks.com/ or follow Stateless on Twitter: @statelessntwrks.see
Glanzmann Enterprises
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Building world-changing companies in sunny Miami
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 627
- Round size: Seed $880k–$7M; Pre-Seed $125k–$3.5M; Series A $5M–$35M
- Lead/follow: 2% lead, 98% follow
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 131
- Round size: Series A $9.5M–$62M; Series B $14M–$135M; Series C $21M–$80M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $296M in 2026
Portfolio highlights
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
- GT Medical Technologies — GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.
Show more...Investment focus
- Industry: Biotechnology, Energy, Software
- Stage:Post-IPO Equity, Debt Financing, Series B
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 23
- Round size: Series B $6.4M–$36M; Debt Financing $100M–$100M; Post-IPO Equity $12M–$195M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- FalconX — FalconX is a reliable Institutional Crypto Trading Platform built for financial institutions. We simplify the complex landscape of digital assets and for our institutional clients with seamless price discovery and trade execution strategies at zero slippage and no hidden fees.
- Semler Scientific — Semler Scientific provides medical technology and software enabling point-of-care testing for early chronic disease detection.
- Caledonia Mining Corporation — Caledonia Mining Corporation operates as a mining, exploration, and development company focused on Southern Africa. Caledonia's primary asset is a 49% interest in the Blanket Mine in Zimbabwe which produced over 42,800 ounces of gold in 2015 at a cash cost of US$701/oz.Blanket Mine, ZimbabweThe Blanket gold mine re-started production inApril 2009 after a temporary shut-down due to the economic difficulties in Zimbabwe. In late 2010, Blanket successfully completed an expansion project which increased production capacity from 24,000 ounces of gold per annum to 40,000 ounces of gold per annum.As an indigenized entity, Blanket can implement its long term growth strategy. The Blanket board, which includes representatives of the Indigenous Zimbabwean shareholders, approved a capital investment program for a 4 year growth strategy for 2014 to 2017. This investment program, which was endorsed by the Caledonia Board, is estimated at US$65 million, will be funded from Blanket's internally generated cash, and is expected to result in progressive increases in gold production.Blanket is engaged in the exploration of the down-dip extensions of the known ore bodies and the first two satellite exploration projects which are within trucking distance of the Blanket metallurgical recovery plant.Blanket's metallurgical plant has substantial surplus capacity. Increased production arising from increased mining throughput could, therefore, be processed with moderate capital investment and incurring only consumable costs to treat any increased throughput.Caledonia has a strong, experienced management team and Board of Directors with diverse expertise in gold production, exploration, mine development, finance, and marketing. Caledonia's management team is based in Johannesburg, South Africa, and Jersey, Channel Islands.Caledonia paid its initial dividend in February 2012. On April 4, 2013 Caledonia announced an annual dividend in respect of the year to December 31, 2012. On November 25, 2013, Caledonia announced that in 2014 it intends to pay an annual aggregate dividend of 6 Canadian cents per common share, payable on a quarterly basis. The first quarterly dividend of 1.5 Canadian cents per common share was declared and paid in January 2014. Further quarterly dividends have bene paid thereafter. On December 16, 2015, Caledonia announced that henceforth it would report its financial results in United States Dollars. The dividend paid at the end of January 2016 was therefore denominated in United States Dollars. The quarterly dividend of 1.125 US cents is Caledonia's revised policy and represents an annual dividend of 4.5 US cents. The Caledonia Board will continue to review dividends which will depend on the performance of the company and its capital investment requirements.
Caju Venture Partners invests in MedTech in the European Union. Caju Venture Partners invests in entrepreneurs with high integrity who can establish great businesses and impact healthcare in the future.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Private Equity
- Geography: Ireland, United States, The Netherlands
Investor stats
- Total investments: 4
- Round size: Series A $11M–$61M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- HiberCell — Developing therapies targeting adaptive-stress driven vulnerabilities to combat treatment resistance, cancer relapse, and metastasis.
- Sigmascreening — Pucuk138 merupakan situs andalan Slot88 official gampang gacor dengan bet 100,200 dan 500 perak Auto Maxwin dengan winrate tertinggi.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 94
- Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $34M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 230
- Round size: Seed $648k–$7.3M; Private Equity $2.1M–$8.3M; Venture - Series Unknown $979k–$6.5M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Vertal — Vertal is a food waste recycling company
- Welding Engineers — Welding Engineers has been in business since 1966 and is a major independent door company specialising in the manufacture, installation, repair and maintenance of all types of Industrial Doors and Shutters, Steel Fabrication, Lift Gates and Shutters, Industrial Roofing and Structural Glazing.
- Industrial Engineering Plastics — Industrial Engineering Plastics delivers specialist thermoplastic fabrication, DW154-compliant ductwork, machining, and plastics distribution
Early-stage venture firm backing founders with world-changing potential. Portfolio includes Hadrian, Flutterwave, Onebrief and Long Wall.
Show more...Investment focus
- Industry: FinTech, SaaS, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Kenya, Nigeria
Investor stats
- Total investments: 30
- Round size: Seed $230k–$3.1M; Pre-Seed $500k–$2.7M; Series A $2.5M–$49M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- idler — Push the frontier of your model
- Juxta — Juxta delivers infrastructure-free positioning for people, assets, and robots. Track indoors, outdoors, and GPS-denied environments with the Universal Positioning System, Software SDK, and Asset Tags.
- Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 21
- Round size: Seed $1.2M–$4M; Series A $4M–$26M; Venture - Series Unknown $6.5M–$97M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
- AICertified — Industry-recognised, accredited AI qualifications built for every learner and organisation.
- SynergySuite — SynergySuite is an international provider of award winning, cloud based enterprise back office software to leading global restaurant chains. SynergySuite offers a modular solution covering all critical business areas including inventory & procurement, recipe management, food safety, scheduling, cash management, human resources, and businessintelligence. After using SynergySuite our customers add between 4% to 6% per location to their bottom line. SynergySuite has been in the industry since 2011 and works with top restaurant chains like KFC, Macaroni Grill, BrewDog, Hawthorne Leisure and many more across the US, UK, and Ireland.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 49
- Round size: Seed $1.4M–$5.9M; Series A $5M–$26M; Series B $6.5M–$60M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $2M in 2010
Portfolio highlights
- Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
Chip Hance
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Expanding nanotechnology into business.
Show more...Investment focus
- Industry: Semiconductor, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, Germany
Investor stats
- Total investments: 55
- Round size: Seed $3.3M–$23M; Series A $9.1M–$72M; Series B $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $322M in 2024
Portfolio highlights
- Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
- Euclyd — Euclyd develops AI infrastructure designed to make advanced AI computing more efficient and scalable. Its platform combines programmable ASIC compute, processor-memory co-design, and system-level optimization to address power, memory, and infrastructure constraints. Its products include craftwerk, an agentic AI silicon platform, and CWS 32, an AIcomputing system focused on low-power exascale performance. Euclyd also develops silicon architecture, systems, firmware, compilers, and runtime software for AI infrastructure.
- NEURA Robotics — Cognitive Robotics for Real-World Applications: NEURA Robotics enables safe and smart robot integration for Industry, Work and Everyday Life
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 1348
- Round size: Seed $1M–$8.1M; Series A $5M–$35M; Venture - Series Unknown $69k–$12M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fresh fund, raised $140k in 2026
Portfolio highlights
- MoneyStack — Financial stress can be an obstacle to mental health recovery. MoneyStack partners with healthcare teams to integrate financial counseling into treatment plans to improve mental health outcomes and support long-term recovery for individuals and families impacted by someone's behavioral health condition.
- Tiny Health — Tiny Health is the first at-home gut health test for moms and babies 0-3 years. Detect any gut imbalances early on and prevent chronic conditions.
- Charter Space — Charter is developing a collaborative platform for satellite mission logistics and program management available via web app and API that provides satellite operators with intuitive information architecture to streamline missions and reduce wasted engineering hours so they can get to the launchpad faster.Charter's platform usesdesign-focused UI/UX and automation to reduce friction through intuitive dashboarding, improved information sharing, and optimized compute and data resource efficiency. For satellite companies, ATLAS streamlines processes, automates manual tasks, and provides engineers with communications and information infrastructure to seamlessly interface both across teams and organisations. reduces wasted engineering hours and lead times, and minimizes upfront technical debt, CapEx, and long-run OpEx.In other words, Charter is building a logistics solution that will be to satellite logistics what the graphical user interface was to command-line interfaces.
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 605
- Round size: Series A $4.1M–$21M; Private Equity $6.4M–$22M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Citrus-Lime — Support notifications from the CitrusLime team. Please note that we don't see tweets sent to this account
- Boost Juice Bars UK — Boost Juice Bars UK offer a range of smoothies and freshly squeezed juice products.
- Thames Card Technology —
Lachy Groom is the Co-Founder of Physical Intelligence. He previously worked at Stripe as the Head of Stripe Issuing.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, India, Canada
Investor stats
- Total investments: 229
- Round size: Seed $2.2M–$10M; Series A $8.5M–$35M; Series B $20M–$80M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Airbound — Welcome to Airbound, where we're reaching the unreachable with our zero infrastructure deliveries. Discover our innovative solutions for efficient and sustainable delivery systems.
- FSH Technologies (formerly Contenda) — Contenda helps repurpose old content into a new engagement. It contextually identifies content's key topics and spins it into the proper format for an audience to discover.
- alteon energy — Alteon develops long-endurance aircraft and unmanned aerial systems for extended-duration flight. Its designs combine solar power and dynamic soaring to support continuous operation.
Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 780
- Round size: Series A $5.3M–$27M; Series B $6.5M–$45M; Debt Financing $2M–$105M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- JetZero — JetZero develops commercial aircraft centered on an all-wing or blended wing body design that integrates the fuselage and wings into a single structure to improve aerodynamics and reduce fuel use. The company is advancing the Z4 airplane, which targets lower fuel consumption and associated emissions compared with conventional tube-and-wing jets,and is working with industry partners on systems like engines, composites, and potential hydrogen fuel adaptations. JetZero collaborates with aerospace suppliers, research organizations, and regulatory bodies to design, test, and prepare full-scale demonstrators with the aim of advancing certification and entry into service. The company’s work includes aerodynamic simulation, structural engineering, and exploring sustainable fuel solutions to address aviation’s environmental goals.
- Zogenix — Therapeutic Solutions for CNS Disorders and Rare Diseases
- Critical Energy — Critical Energy builds modular power plants for geothermal and waste heat recovery, shipped in standard containers and installed in weeks.
Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products. We are also a significant provider of raw materials to the life sciences industry.
Show more...Investment focus
- Industry: Health Care, Wellness, Medical Device
- Stage:Seed, Corporate Round, Convertible Note
- Geography: Ireland, United States
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
- imaware — Join the thousands of Americans who are taking control of their health by screening for conditions from home and proactively engaging their doctors sooner.
Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: United States, Ireland
Investor stats
- Total investments: 25
- Round size: Series A $6.1M–$30M; Series B $16M–$50M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
- Enable Injections — Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators.
- Ponce De Leon Pharmaceuticals — PDLHealth researches and commercializes drug-free solutions focused on longevity, healthspan, and the future of aging science.
Medical Device Investor funding in Ireland at a glance
Stats across 271 deals from 188 investors.
Access all 188 investors in Ireland Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 188 investors investing in Ireland Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!